Proliferation News and Research

RSS

Boston researchers identify new mechanism that inhibit tumor growth in mice

A team of researchers, led by Pier Paolo Pandolfi, at Beth Israel Deaconess Medical Center, Boston, has identified a new type of cellular senescence (i.e., irreversible arrest of cell growth) and determined a way to enhance it to suppress prostate tumor development and growth in mice.

9 Feb 2010

Study could lead to non-surgical alternatives for tonsillectomies

Children with obstructive sleep apnea (OSA) may one day be able to have an injection or use a throat spray instead of getting their tonsils removed to cure their snoring, according to a new study from the University of Chicago, which found that a specific gene product may be responsible for the proliferation of adenotonsillar tissue that can cause pediatric OSA.

4 Feb 2010

Questionable health insurance plans cause concern

Officials worry that people with no insurance will be drawn in by questionable health insurance plans. ABC News reports: The "[h]ealth care overhaul is stalled, resulting in a proliferation of plans that don't fully protect people, officials said. Watchdogs worry about two kinds of plans in particular."

3 Feb 2010

Research suggests growth factor gene plays a central role in palate development

Cleft palate has been linked to dozens of genes. During their investigation of one of these genes, researchers at Washington University School of Medicine in St. Louis were surprised to find that cleft palate occurs both when the gene is more active and when it is less active than normal.

3 Feb 2010

Compugen discovers CGEN-15001 protein for treatment of autoimmune disorders

Compugen Ltd. announced today the discovery and experimental validation of CGEN-15001 for the treatment of autoimmune disorders.

2 Feb 2010

Study evaluates hepatocyte transplantation as an alternative to liver transplantation

A research team from the National Taiwan University Hospital has evaluated the efficiency of transplanted hepatocyte (liver) cells in animal models severely damaged by two kinds of chemical toxicity to see whether and how transplanted hepatocytes were able to efficiently repopulate the toxin-induced, severely damaged livers.

2 Feb 2010

One-third of dairy products exceed microbe contamination levels, says study

One-third of samples of milk and dairy products analysed in various restaurants exceed the microbe contamination limits set by the European Union, according to a study carried out by researchers from the University of Valencia (UV). The experts advise against keeping milk in jugs and suggest that these foodstuffs need to be better handled.

30 Jan 2010

Global market for oncology drugs is forecast to reach $80 billion by 2050

New Medicine's Oncology KnowledgeBASE (nm/OK) residing at http://nmok.net became available on the Internet 10 years ago and, since then, the oncology field has evolved into one of the most challenging, complex and promising drug development sectors, both in terms of its potential contribution to medicine and to its market opportunities.

29 Jan 2010

Universal Detection Technology responds to the U.S. Government's failure to address bioterrorism

Universal Detection Technology (www.udetection.com), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, responded today to a bipartisan congressional committee’s scathing report card failing the U.S. Government for adequately preparing the country for the threat of a bioterrorism attack.

29 Jan 2010

Oculus Innovative Sciences introduces Microcyn Solution for treatment of post-surgical wounds

Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.

28 Jan 2010

WHO addresses handling of H1N1 at Council of Europe meeting

During a Council of Europe meeting on Tuesday to address the WHO's handling of the H1N1 virus, the WHO said it had not "fallen under the sway of drugs firms and exaggerated the dangers of the H1N1 flu virus, but said it might have handled the crisis better," Reuters reports.

27 Jan 2010

Researchers challenge prevailing belief about role of protein in abnormal cell proliferation

In a study to be published this week, a research team is challenging a prevailing belief about the behavior of a human protein linked to the formation of cancer, possibly breathing new life into the search for therapies that will inhibit that protein from "turning on" genes involved in abnormal cell proliferation.

27 Jan 2010

GEH to create a supply of molybdenum-99 for use in nuclear medicine diagnostic procedures

GE Hitachi Nuclear Energy (GEH) announced today it has been selected by the U.S. Department of Energy’s National Nuclear Security Administration (NNSA) to help develop a U.S. supply of a radioisotope used in more than 20 million diagnostic medical procedures in the United States each year.

27 Jan 2010

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The

27 Jan 2010

UCSB research: Rapamycin drug, a potential treatment for ADPKD

Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease. The study builds on past research and shows that studies performed on mice are more likely to translate to humans than previously thought.

27 Jan 2010

OrbusNeich's clinical data demonstrates the benefits of Genous Bio-engineered R stent

OrbusNeich announced that clinical data presented today at Asia PCR/Singapore LIVE 2010 demonstrated the benefits of the Genous Bio-engineered R stent in the treatment of two challenging patient subsets.

24 Jan 2010

Study: Warburg effect promotes rapid cell proliferation and tumor growth

A team of scientists led by Professor Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory has discovered molecular factors in cancer cells that boost the production of an enzyme that helps alter the cells' glucose metabolism. The altered metabolic state, called the Warburg effect, promotes extremely rapid cell proliferation and tumor growth. Adrian Krainer, Ph.D.

23 Jan 2010

The American Journal of Pathology: Highlights from February 2010 issue

A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.

22 Jan 2010

Postdoctoral scientists receive prestigious award; grants totaling $1.54 million will help in funding innovative projects

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting exceptional early career researchers and innovative cancer research, named 11 new Damon Runyon Fellows at its November 2009 Fellowship Award Committee review.

22 Jan 2010

Researchers discover genetic variations that predict clinical outcomes in patients with stomach cancer

Researchers at the University of Southern California (USC) have, for the first time, identified specific genetic variations that predict clinical outcomes in patients with gastric (stomach) cancer.

22 Jan 2010

Proliferation News and Research

Boston researchers identify new mechanism that inhibit tumor growth in mice

Study could lead to non-surgical alternatives for tonsillectomies

Questionable health insurance plans cause concern

Research suggests growth factor gene plays a central role in palate development

Compugen discovers CGEN-15001 protein for treatment of autoimmune disorders

Study evaluates hepatocyte transplantation as an alternative to liver transplantation

One-third of dairy products exceed microbe contamination levels, says study

Global market for oncology drugs is forecast to reach $80 billion by 2050

Universal Detection Technology responds to the U.S. Government's failure to address bioterrorism

Oculus Innovative Sciences introduces Microcyn Solution for treatment of post-surgical wounds

WHO addresses handling of H1N1 at Council of Europe meeting

Researchers challenge prevailing belief about role of protein in abnormal cell proliferation

GEH to create a supply of molybdenum-99 for use in nuclear medicine diagnostic procedures

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

UCSB research: Rapamycin drug, a potential treatment for ADPKD

OrbusNeich's clinical data demonstrates the benefits of Genous Bio-engineered R stent

Study: Warburg effect promotes rapid cell proliferation and tumor growth

The American Journal of Pathology: Highlights from February 2010 issue

Postdoctoral scientists receive prestigious award; grants totaling $1.54 million will help in funding innovative projects

Researchers discover genetic variations that predict clinical outcomes in patients with stomach cancer

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News